Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Alx Oncology Hldgs Inc (ALXO)

69 + Investors. Track Smart Money conviction in ALXO. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +13
Streak
1Q ▲
Buyers last Q
65%

Smart Money Signals — ALXO

Based on 69 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added ALXO than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🔻

Below peak — only 63% of 3.0Y high

63% of all-time peak
Only 69 funds hold ALXO today versus a peak of 109 funds at 2024 Q2 — just 63% of the maximum. Low institutional ownership can mean the stock is out of favor, but it also means there's a large pool of potential buyers if sentiment turns.
📉

Outflows — 18% fewer funds vs a year ago

fund count last 6Q
15 fewer hedge funds hold ALXO compared to a year ago (-18% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟢

More buyers than sellers — 65% buying

45 buying24 selling
Last quarter: 45 funds were net buyers (25 opened a brand new position + 20 added to an existing one). Only 24 were sellers (12 trimmed + 12 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+18 vs last Q)

new funds entering per quarter
Funds opening a new ALXO position: 10 → 8 → 7 → 25. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

46% of holders stayed for 2+ years

■ 46% conviction (2yr+) ■ 25% medium ■ 29% new
32 out of 69 hedge funds have held ALXO for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +464% but shares only +222% — price-driven

Value
+464%
Shares
+222%
Last quarter: the total dollar value of institutional holdings rose +464%, but actual share count only changed +222%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

9 → 10 → 8 → 7 → 25 new funds/Q
New funds entering each quarter: 10 → 8 → 7 → 25. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 56% veterans vs 27% newcomers

■ 56% veterans ■ 17% 1-2yr ■ 27% new
Entry-cohort mix of 71 holders: 40 (56%) are 2+ year veterans, 12 entered 1–2 years ago, and 19 (27%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
📋

Smaller funds dominant — 6% AUM from top-100

6% from top-100 AUM funds
19 of 68 holders rank in the top 100 by AUM, but together hold only 6% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
1.9
out of 10
Low Exit Risk
Exit risk score 1.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ALXO

In 2026 Q1, 45 hedge funds were net buyers of ALXO (25 opened a new position, 20 added to an existing one), while 24 reduced or exited (12 trimmed, 12 sold completely) — a 65% buyer ratio, indicating clear institutional accumulation. Net fund flow last quarter: +13 funds (more new holders than closures). Total institutional holders: 69.

Hedge Fund Ownership: ALXO

How many hedge funds hold ALXO — quarterly history vs. share price
Quarterly hedge fund ownership of ALXO vs. share price

Market Analysis: ALXO

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ALXO

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Alx Oncology Hldgs Inc (ALXO) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much ALXO has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 88d ago
ALXO
-10.7%
XLV
+9.2%

ALXO outperformed XLV by -19.9% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 43d ago
ALXO
-11.8%
XLV
+10.3%

Since the filing became public, ALXO outperformed XLV by -22.1% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

7 top-rated funds 0 high-conviction
Consensus
3.9
/ 10
breadth
×
Elite
1.2
/ 10
conviction
Hedge Fund Positioning: ALXO
69 + Investors

Track Smart Money conviction in ALXO. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 69 56 23.21%
13F Shares 95M 29M 222.45%
Total Value $188M $33M 463.95%
New Positions 25 7 +18
Increased Positions 18 18 -
Closed Positions 12 12 -
Reduced Positions 11 15 -4
Total Calls 2 3 -33.33%
Total Puts 1 3 -66.67%
PUT/CALL Ratio 0.5 1.0 Bullish

Statistics: ALXO

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

69 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ALXO. Verified SEC 13F-HR filings.

QUARTER:
Top 25 ALXO holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 venBio Partners LLC 9.21% 12,884,638 $25.8M
2 5AM Venture Management, LLC 1.70% 3,057,325 $6.1M
3 Almitas Capital LLC 1.44% 3,173,834 $6.4M
4 Squadron Capital Management LLC 1.07% 1,460,000 $2.9M
5 Redmile Group, LLC 1.06% 7,964,188 $16.0M
6 Caxton Corp 1.04% 20,946 $42K
7 TCG Crossover Management, LLC 0.75% 13,011,849 $26.1M
8 Vivo Capital, LLC 0.53% 3,184,713 $6.4M
9 Ra Capital Management, L.P. 0.28% 13,011,849 $26.1M
10 Orbimed Advisors LLC 0.11% 2,866,256 $5.7M
11 Driehaus Capital Management LLC 0.08% 5,734,620 $11.5M
12 Blackstone Inc. 0.05% 5,826,544 $11.7M
13 HC Advisors, LLC 0.03% 22,900 $46K
14 Marshall Wace, LLP 0.01% 3,757,216 $7.5M
15 JSF Financial, LLC 0.01% 17,500 $35K
16 Adage Capital Partners GP, L.L.C. 0.01% 2,000,000 $4.0M
17 NINE MASTS CAPITAL Ltd 0.01% 20,623 $41K
18 Abel Hall, LLC 0.01% 12,598 $25K
19 Ensign Peak Advisors, Inc 0.00% 950,550 $1.9M
20 Bridgeway Capital Management, LLC 0.00% 76,072 $153K
21 Two Sigma Investments, LP 0.00% 1,587,833 $3.2M
22 Two Sigma Securities, LLC 0.00% 10,993 $22K
23 Renaissance Technologies LLC 0.00% 732,599 $1.5M
24 Graham Capital Management, L.P. 0.00% 37,739 $76K
25 Millennium Management LLC 0.00% 1,988,559 $4.0M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Alx Oncology Hldgs Inc (ALXO)

What does the Smart Money Trend signal show for ALXO?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added ALXO than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ALXO?

More buyers than sellers — 65% buying: Last quarter: 45 funds were net buyers (25 opened a brand new position + 20 added to an existing one). Only 24 were sellers (12 trimmed + 12 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for ALXO holders?

Smaller funds dominant — 6% AUM from top-100: 19 of 68 holders rank in the top 100 by AUM, but together hold only 6% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held ALXO?

46% of holders stayed for 2+ years: 32 out of 69 hedge funds have held ALXO for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Alx Oncology Hldgs Inc (ALXO) following the 2026 Q1 hedge fund 13F filings?

As of today, ALXO has moved -11.8% since the 2026 Q1 13F filing date (May 15, 2026), compared to +10.3% for the XLV sector ETF — an outperformance of -22.1%. Since the quarter end (March 31, 2026), ALXO has gained -10.7% vs +9.2% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →